Abstract Functional dependency (needing help with basic ADLs) is an important outcome in Parkinson's disease (PD). ''Death or dependency'', as opposed to being alive and independent, is a useful dichotomous indicator of poor outcome. We aimed to systematically review the progression to dependency in PD and what factors predicted development of dependency. Comprehensive searches were performed to identify observational studies of dependency in PD with follow-up of at least 3 years. Other forms of parkinsonism and highly selected cohorts were excluded. Descriptive analysis of included studies was performed and outcomes over time were plotted by type of cohort (inception/non-inception). Independent prognostic factors were identified. There were insufficient data for meta-analysis. Of 15,154 unique references identified, 14 studies were included. Most studies were of low quality. There was heterogeneity in definitions of dependency and the measured risk of dependency at similar time-points. Risk of dependency in inception studies was about 10-25 % at 5 years and about 20-50 % at 10 years; and risk of ''death or dependency'' in the inception studies was about 15-40 % at 5 years and about 35-70 % at ten years. More bradykinesia and older age were associated with more dependency, but there was little evidence for other prognostic factors. Few high-quality data on dependency are available. Heterogeneity in study populations, methodology and outcome reporting made data synthesis difficult. Few prognostic factors have been identified. Further data from representative inception studies are necessary to better understand the progression of dependency in PD.
Introduction
Disability and loss of independence are important and useful outcome measures in Parkinson's disease (PD).The term ''disability'' has been used variably in the literature, often being confused with impairment (the signs and symptoms of disease), or used broadly to describe adverse consequences of disease. Disability is defined as limitation in functional performance and activity [1] , and has also been termed activity limitation [2] . Disability has distinct advantages over other clinical measurements in PD including (i) being directly relevant to those suffering from the disease (as opposed to measures of impairment) and (ii) being relatively objective and easy to measure (unlike quality of life).
An important aspect of disability which can be defined objectively is dependency, which is defined as being dependent upon others for help with basic activities of daily living (ADLs), such as washing, dressing, toileting and feeding. Dependence can be defined from disability scales, such as the Schwab & England [3] (score\80 %) or the Barthel index [4] ; from other scales which include disability amongst other items (e.g. a Hoehn & Yahr score C4) [5] .
Combining dependency with death, to derive a composite outcome measure, ''dead or dependent'', encapsulates poor outcome in PD. Reporting dependency risk only in survivors may underestimate overall poor outcome because more severely affected individuals are likely to die earlier and, therefore, would be excluded from 'survivor only' measures. Although first used in PD by Hoehn & Yahr in 1967 , in their seminal paper on the epidemiology of PD, it has seldom been used since.
Two previous systematic reviews of disease progression have been published, both focussing on the identification of prognostic factors and including data on disability [6, 7] but no systematic review of the development of, or predictors of, development of dependency have been published. We, therefore, aimed to (i) conduct a systematic review of the progression to dependency in cohorts with PD and (ii) to identify which factors have been associated with more dependency.
Methods
This systematic review was conducted according to a predefined protocol (http://www.abdn.ac.uk/iahs/documents/ AM_Disability_systematic_review_protocol.pdf).
Inclusion/exclusion criteria
We included all observational studies describing the development of dependency over time in PD, with followup of at least 3 years, reporting quantitative measures of dependency using any definition of dependency. We also identified studies reporting other disability outcomes, but do not present the results from these studies in this paper, because few new data were published since previous reviews of disability in PD [6, 7] . The initial protocol was modified after the literature searches were performed to only include studies with follow-up of at least 3 years rather than 1 year as initially intended because shorter studies would be less informative. Older studies, where the intention was to recruit idiopathic PD, but which were carried out before atypical parkinsonian features were clearly identified, were included. We excluded cross-sectional studies as they are inappropriate for studying disease progression [8] . We excluded studies of parkinsonism in general or other forms of parkinsonism; highly selected cohorts (for example only young onset, or surgically treated patients); and drug trials where subjects who stopped taking the trial drug or violated the protocol were not followed up. We also excluded articles in non-European languages as we had no access to translation services and studies published only in abstract form.
Literature searches
We searched several electronic databases (MEDLINE from 1946, Embase from 1947, and CINAHL from 1988, last searched 9/7/13) and reviewed reference lists of included studies and relevant reviews identified in the search. The electronic searches used keywords and free-text terms for PD combined with terms for disability or dependence (see online resource 1).
Assessment of studies
Titles and abstracts of studies identified from the search strategy were reviewed by one author (ADM) and the full text of potentially relevant articles was obtained. European language articles were translated using the website translate.google.co.uk. We pre-defined three items to assess risk of bias in each study [representativeness (community-based studies without major exclusions), adequate confirmation of diagnosis (established criteria or other criteria which excluded a range of features suggestive of other diagnoses) and adequate study attrition (fewer than 5 % loss to followup per year, other than by death)].
Data extraction
Two reviewers (ADM and JWKG) extracted data on methodological features, demographic characteristics and disability outcomes from full text articles to a data extraction form, unblinded to study details (as blinding is time-consuming and only minimally influences results) [9] . Agreement was high and all differences were resolved by discussion.
Statistical analyses
We conducted a descriptive analysis in which proportions dependent, and proportions ''dead or dependent'' from individual studies were plotted against follow-up time or, for some analyses, against approximate mean disease duration. The ideal denominator for percentages of subjects dependent at particular time-points would be the total cohort (i.e. alive and dead) but because several studies did not report the number of deaths we used the total number alive. Analyses were stratified by cohort type [inception (i.e. all participants recruited at diagnosis, or described as ''recently'' or ''newly'' diagnosed) or non-inception]. Meta-analysis was not performed as too few studies reported specific outcome measures at similar follow-up times.
Prognostic factors were tabulated, including all factors examined for association with dependency (where reported) and which of these were independently associated.
All statistical analyses were performed using Stata version 12.1 (StataCorp LP, College Station, Texas).
Results
Search strategy results Figure 1 shows the results of the searches and the reasons for excluding references. We included 14 studies [5, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Included studies
The methods of the included studies are displayed in Table 1 . Five studies were inception cohorts (studies recruiting only patients at or near diagnosis) [5, 11, 12, 16, 19] and nine were non-inception cohorts (e.g. prevalence studies, consecutive series) [10, 13-15, 17, 18, 20-22] . Thirteen studies were hospital based [5, 10, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] and one was community based [11] . Nine studies were retrospective [5, 12, 14, 15, 17, 18, [20] [21] [22] and five were prospective [10, 11, 13, 16, 19] . One study was published before the introduction of levodopa [5] , three straddled its introduction [15, 18, 20] and the rest were carried out when levodopa was widely available [10-14, 16, 17, 19, 21] . No study met all three of the pre-specified risk-of-bias criteria.
No study was considered to be representative: all were either hospital clinic based or had exclusion criteria. Nine studies used adequate methods for diagnostic confirmation [10, 11, 13-17, 19, 22] and five were inadequate or not stated [5, 12, 18, 20, 21] . Five studies had adequate losses to follow-up [5, 11, 12, 16, 19] and nine studies had excessive losses to follow-up or did not state the number of losses to follow-up [10, 13-15, 17, 18, 20-22] . The median mean age at onset was 60, and the median mean disease duration at baseline was 2.5 years, in the studies which reported these data.
Dependency
Four inception cohorts [5, 11, 12, 16, 19] and nine noninception studies [10, [13] [14] [15] [17] [18] [19] [20] [21] reported risk of dependency ( Fig. 2 and online resource 2) . In most studies dependency was defined as Hoehn & Yahr stage greater than three, one study also used Schwab & England score \80 % and four studies did not use a particular scale to define dependency. In each study which reported dependence risk, except one study [18] there was a steady increase in risk of dependence over time with approximately the same rate of increase across studies. There appeared to be major heterogeneity in the baseline risk of dependence in the non-inception cohorts, but there was more homogeneity in the inception cohorts. Because mean baseline disease durations in the non-inception studies varied widely, an alternative plot of the data in Fig. 2b , where dependence in non-inception studies is plotted against approximate mean disease duration, is shown in online resource 3. There is less heterogeneity in this figure, suggesting that the different disease durations may be an important cause of heterogeneity in non-inception studies. However, the disease durations on this graph are imprecise and should be interpreted with caution (see footnote to online resource 3). On the basis of the data in Fig. 2a , assuming that there is a linear rise in disability between the time-points reported, we can estimate that in the inception cohorts, 10-25 % of surviving patients were dependent at 5 years and about 20-50 % were dependent at 10 years. One study reported mean time to dependence was 12.8 years (SD 7.0) [22] . No study reported median time to dependence, but interpolating data from the reported dependency risks, suggests that the median time to dependence in inception studies is about 10-15 years. One study reported data using both Schwab & England and Hoehn & Yahr scales from which dependency could be derived [19] , but at 12 years the proportions dependent were markedly different depending on which scale was used (68 and 36 %, respectively).
Death or dependence
Four inception cohorts [5, 11, 12, 16] and one non-inception cohort [10] reported ''death or dependency'' ( Fig. 3 and online resource 2). The results from these studies were homogenous early in the disease course, although later in the disease course one study had lower estimates than the other two studies. On the basis of the data in Fig. 3 , assuming that there is a linear rise in ''death or dependence'' between the time-points reported, we can estimate that in the inception studies, at 5 years about 15-40 % were dead or dependent and at 10 years about 35-70 % were dead or dependent. The single estimate of proportion ''dead or dependent'' in the non-inception study showed a higher proportion dead or dependent than in the inception studies: 49 % at 5 years.
There was no consistent evidence of slower accumulation of dependence or ''death or dependence'' in more recent studies compared to older studies. Although one inception study carried out in the levodopa era with similar methods to the only pre-levodopa study [8] showed consistently lower proportions dependent and dead or dependent at each time-point, other inception studies carried out in the levodopa era had similar levels of dependence/death or dependence to the pre-levodopa study.
Prognostic factors for dependency
Only two studies reported baseline factors (i.e. measured at recruitment to the study), which were independently associated with more dependence (see Table 2 ) [13, 20] . The only consistent finding between these two studies was that bradykinesia and not tremor was independently associated with more dependency. One of these studies reported that older age was associated with a greater risk of becoming dependent and presentation of results stratified by age in the other study suggested a strong effect of age on the development of dependence although this was not tested in the multivariable analyses.
Discussion
The overall quality of the studies included in this review was low, with only two studies meeting all pre-specified quality criteria. Results from these studies are heterogeneous, in terms of definitions used, time-points outcomes were measured and the dependence risks reported at similar time-points, although the inception studies reported more consistent results. The proportion of patients dependent in inception studies was about 10-25 % at 5 years and about 20-50 % at 10 years. The proportion of patients ''dead or dependent'' in the inception studies was about 15-40 % at 5 years and about 35-70 % at 10 years. There was a lack of good-quality epidemiological data to determine whether levodopa has or has not slowed the accumulation of dependency. There was a dearth of data on predictors of greater dependence, but what evidence there is suggests that bradykinesia rather than tremor and older age are risk factors for greater dependence. These findings are consistent with previous data on risk factors for greater disability [6, 7] . The main limitations of this review relate to the limitations of the primary studies. There are several methodological attributes of the studies included in this review which may introduce bias into the reported disability measures and prognostic factors. The use of non-inception cohorts introduces selection biases, including survival bias (those with longer disease duration and slower disease progression will be more likely to be recruited) [23, 24] . Recruitment of patients only from hospital or specialist clinics also introduces referral bias: older people and those with lower socioeconomic status are less likely to be referred [25] . Evidence of this was apparent from the median mean age of onset in the studies included in this review (60) being lower than the mean age of onset in community-based incident studies (around 70) [26] [27] [28] [29] . Exclusion criteria (other than those relating to accuracy of diagnosis) will also introduce selection bias. It has been shown that estimates of mortality are influenced by differences in diagnostic accuracy (''possible'' PD may have a higher mortality rate than ''definite'' PD) [30] ; and this may be true for other prognostic outcomes, including dependency. Some of the early studies would have included atypical parkinsonism and this contributes to the heterogeneity between older and newer studies. High losses to follow-up were another potential source of selection bias. Similar flaws in the design of prognostic studies are widespread across many clinical areas [31] .
It is important that definitions for dependence are valid and reliable. Unfortunately, the scales used have not been validated fully [32] and there may be variation in the way they are interpreted. Some scales lack construct validity, combining different domains of disease outcome, such as the Hoehn & Yahr scale (pathology, disease impairment and disability) [33] . The Barthel Index may be a better measurement than the scales used in the studies included in this review [4] , but it has not been validated fully in Parkinson's disease [34] . One study reported data showing widely differing proportions of dependence, contingent on the definition used (Hoehn & Yahr [3 or Schwab & England \80 %) [19] . Thus, studies defining dependence using the Schwab & England scale may identify higher risk of dependence than studies using the Hoehn & Yahr scale. However, the data presented on dependence and death or dependence from inception studies all used the same definition of dependence (Hoehn & Yahr score [3) . it is likely this cutoff has not always been interpreted as a definition of dependence when used in research studies or in clinical practice. These problems with the scales used for defining disability and dependence may be responsible for some of the heterogeneity in the outcomes reported.
The limitations of the review, rather than of the original studies, include the possibility of missing articles including data on dependency, where this was not the focus of the paper and, therefore, dependency might not appear in the abstract or the keywords used for indexing. The method for assessing study quality was limited, but given the generally poor quality on the crude scale, using a more sophisticated scale probably would not have yielded any additional insights into study quality. Excluding studies in nonEuropean languages may also have introduced bias. The strengths of this systematic review included the use of a protocol with pre-specified analysis plans, comprehensive literature searches, and thorough assessment of individual studies' methodology and results.
In conclusion, overall risk of dependency in inception studies was about 10-25 % at 5 years and about 20-50 % at 10 years; and risk of ''death or dependency'' in the inception studies was about 15-40 % at 5 years and about 35-70 % at 10 years. More bradykinesia and older age were associated with more dependency. However, poor data quality and heterogeneity of results prevented formal synthesis of the data in this review. Further studies of this clinically relevant outcome and its predictors should be carried out and it is important that these studies are of high quality. The PROGRESS group, a collaboration of academics with an interest in prognosis research, has recently published recommendations for improving the quality of prognostic studies [31, 35] . We additionally suggest specific recommendations for studies of dependency in PD, which are equally applicable to other aspects of disease progression in PD, and are similar to our previous recommendations regarding studies of mortality [36] . We recommend these studies should: (i) be inception cohorts (ideally incident cohorts-those which aim to recruit all newly diagnosed cases, in a specified area, in a specified time period); (ii) be community based; (iii) have expert confirmation of diagnosis using validated diagnostic criteria; (iv) have no exclusion criteria (other than those related to accuracy of diagnosis); (v) have prospective follow-up; (vi) measure long-term outcomes; and (vii) use valid and reliable outcome measures for dependency with clear definitions of what constitutes dependency. Further research should investigate what is the best way to define and measure dependence in longitudinal clinical studies. Lastly, although ''dead or dependent'' has been used infrequently as an outcome measure, it is a simple global measure of poor outcome and previous data suggest it would be an efficient measure for use in clinical trials [37] . We, therefore, believe it deserves more widespread use. 
